Related Experiment Video
Updated: Jun 28, 2025

09:03
Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
9.8K
Flavonoids with Anti-Angiogenesis Function in Cancer
1School of Medicine, Anhui Xinhua University, 555 Wangjiang West Road, Hefei 230088, China.
Molecules (Basel, Switzerland)
|April 13, 2024
Summary
Plant-derived flavonoids show promise as natural anti-angiogenic agents for cancer therapy. This review explores their mechanisms, targeting key signaling pathways like HIF-1α/VEGF.
Area of Science:
- Molecular Biology
- Pharmacology
- Plant Biochemistry
Background:
- Angiogenesis, the formation of new blood vessels, is crucial for cancer development and progression.
- Current anti-angiogenic therapies often involve expensive or toxic synthetic compounds and antibodies.
- There is a critical need for affordable, less toxic, and effective anti-angiogenic agents.
Purpose of the Study:
- To review the anti-angiogenic properties of naturally derived flavonoids from plants.
- To elucidate the molecular mechanisms through which these flavonoids exert their anti-angiogenic effects.
- To summarize flavonoid structures, classifications, and their interactions with plant signaling pathways.
Main Methods:
- Literature review of studies on plant-derived flavonoids and their anti-angiogenic activities.
- Analysis of molecular mechanisms, focusing on key signaling pathways involved in angiogenesis.
- Summary of flavonoid structure-activity relationships and their classification.
Main Results:
- Naturally derived flavonoids exhibit significant anti-angiogenic potential.
- Flavonoids modulate critical signaling pathways including HIF-1α/VEGF/VEGFR2/PI3K/AKT, Wnt/β-catenin, JNK1/STAT3, and MAPK/AP-1.
- Plant-derived flavonoids offer a promising alternative to synthetic anti-angiogenic drugs.
Conclusions:
- Plant-derived flavonoids represent a valuable source of novel anti-angiogenic compounds.
- Understanding their molecular mechanisms provides a basis for developing new cancer therapies.
- Further research is needed to improve flavonoid bioavailability for clinical applications.
Related Concept Videos
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Mechanism of Angiogenesis
5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K

